Member Info for Harrywilliam

How do you get 10, if that’s correct SP should be at least double what it is

Https://www.google.com/url?q=https://www.forbes.com/sites/davidphelan/2025/01/29/apples-new-game-changer-iphone-update-brings-starlink-satellite-access/&sa=U&sqi=2&ved=2ahUKEwio7L6uh52LAxX9SkEAHSrhIO8Qr_oDKAB6BAgWEAE&usg=AOvVaw1y3miFW4UU8dxynGhCbVCV

Did anybody contact the company to ask about the governments plan to stop investing in the 3 of the 6 ships that the msi guns are on and the financial impact

I was referring to this John

as there's a lot more background info to come out which may change the course of the company. Its just a matter if time and being patient.

Please elaborate John

I’ve never seen the pipeline reported anyway like this
Khan says the number of queries being received from potential customers are “greater than they’ve ever been” and the sales pipeline of potential challenge trials being discussed with clients is valued at over £300 million.

£1.25 million

Yes same with me on iweb

When a say a bit, I mean a lot. Without sounding like a ramping idiot the price could easily double again by year end once rumours of imminent very large dividends commence. So yes the turkey will be the biggest Bernard matthews has ever seen this year

So picking up in interviews etc we can expect news on the following in next few months.
1). More flu challenge study contracts
2). Testing of anti viral contract (s) one imminent
3). Another RSV contract
4). Third challenge study testing facility, maybe a fourth which leads on to...
5). ...multiple further covid challenge studies at £10 million a pop each.

That’s the boring stuff over ??
6). Imutex sale- big dividend
7). Wearables sale/ contracts- big divi
Also new exciting stuff
8). Development of 2-3 new challenge study models - funded by big pharma which leads to
9). More new challenge study trials

Anybody think the share price has a bit more to go ??. What have a missed?

Agree lots of demand for shares today at 26.5p

Today’s RNS is a whisker away from confirming revenues for open orphan will be in excess of 100 million GBP in 2021 which brings a market cap of £300 million plus in play. That’s a share price of 45p + not including dividends for imutex and wearables.

My thoughts are it will be related to covid challenge study model and contracts. Or could it be prep biopharm which has gone a bit quiet

Is the interview on 3rd June now available

I see cathal is presenting again tomorrow night. Wonder if news and updated presentation tomorrow in advance of this presentation. The new presentation should read very well

I’m sure cathal mentioned another 4.5 million contract ready to go. Might get that next week as he wouldn’t have wanted to spike share price this week before placing announcement

The beauty about this share is that there could be news on a whole range of different things on Tuesday and any day after. There’s so much expected newsflow in the pipeline and then we also get surprises like quotient antibody testing. Who was expecting that?

Would they consider raising funds to develop coronavirus challenge study to keep it 100% owned by orph or still plan to fund from 3rd party investment

20-30p for your shares plus a stake in the spin off business which could be huge in its own right if the flu v or mosi vaccine come to fruition. What’s not to like about this investment. Exciting times

Bought in for the first time on Friday. Might have picked a gud un by the looks of things